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Cleistanthin B, one of the toxic constituents of Cleistanthus
collinus, was found to be cytotoxic to normal and tumour
cells. In comparison with normal cells, tumour cells were
sensitive to lower doses of toxin. The 50% growth inhibition
(GI50) values for normal cell lines were from 2 x 10~s to
4.7 x 10"4 M and for tumour cells the values ranged from
1.6 X lO"6 to 4 x lO-5 M. Short exposure (30 min) of Chinese
hamster ovary (CHO) cells to cleistanthin B at 1-6 ug/ml
resulted in extensive chromatid and isochromatid breaks
and gaps. However there was no significant increase in cell
death and DNA strand breaks in cells treated under the
above conditions. Cleistanthin B induced micronucleus
formation in cultured lymphocytes in a dose-dependent
manner. CHO cells treated with high doses of cleistanthin
B showed a decrease in cell viability and a concomitant
increase in DNA strand-breaks. The cell death appears to
be due to apoptosis since nucleosome-like ladders were
observed in the treated cells when the DNA was electrophor-
ized in agarose gels.
Introduction
Cleistanthin B is a naturally occurring compound isolated from
the plant Cleistanthus collinus (Roxb) Benth and Hook (family
Euphorbiaceae). It is a small tree found in dry forests of
central and southern India. The plant is extremely poisonous
and astringent. Extracts of leaves, roots and fruits are used in
acute gastro-intestinal disorders. The extracts are also used as
suicidal and homicidal poisons. The active principles isolated
from the leaves of C.collinus are cleistanthin B, cleistanthin
A, collinusin, diphyllin and elagic acid (Chopra et al, 1965).
Cleistanthins cause neutrophilic granulocytosis in rats, mice,
cats and monkeys (Rao and Nair, 1970). Granulocytopenia
induced by i.p injection of cyclophosphamide could be pre-
vented by the glycoside cleistanthin (Rao and Nair, 1971). The
alcoholic extract of the whole plant exhibited anti-proliferative
activity against human epidermal carcinoma of the nasopharynx
in tissue culture (Bhakuni et al, 1969). All patients who
succumbed to C.collinus poisoning had cardiac signs in the
form of tachycardia followed by brachycardia, low pulse rate,
hypotension and arrhythmias (Nagaraj, 1987). The LDJQ value
of cleistanthin B in mice is 1.2 mg/kg body weight. I.v. and
i.p. administration of cleistanthin B to rats and rabbits resulted
in decreased serum levels of alkaline phosphatase, lactate
dehydrogenase, glutamate oxaloacetate transaminase and glu-
tamate pyruvate transaminase. The isoenzyme pattern of lactate
dehydrogenase showed that the toxin affects heterologous
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isoenzymes while the homologous isoenzymes remain
unaltered (Annapoorni et al, 1986).
Since the crude extract of C.collinus was shown to possess
anti-proliferative activity (Bhakuni et al, 1969), we initiated
this study to determine the cytotoxic and genotoxic effects of
the chief toxic principle, cleistanthin B, in a panel of normal
and tumour cell lines, with the objective of exploring this
toxin as an anti-tumour agent. We investigated the genotoxic
effects of cleistanthin B in Chinese hamster ovary (CHO) cells
and cultured blood lymphocytes. Genotoxicity was evaluated
using DNA strand breaks assay (Olive et al, 1988), chromatid
aberration (CA) analysis (Preston et al., 1981; Ishidate et al,
1988) and micronucleus (MN) assay using cytochalasin B
(cyt-B) (Fenech and Morley, 1985). In addition, we observed
that cleistanthin B induces apoptosis in cultured cells.
Materials and methods
Chemicals
Cleistanthin B was purified from C.collinus leaves as previously described
(Govindachari et ai, 1969). Cytochalasin B was dissolved in dimethyl
sulphoxide (DMSO) at a concentration of 2 mg/ml and stored at -70°C. At
the time of experiment the stock solution was diluted with phosphate-buffered
saline (PBS) and added to cultures at a final concentration of 6 Hg/ml.
Erythrosin B, cytochalasin B, phytohaemagglutinin (PHA) and 3-{4,5 dimethyl
thiazol-2-yl)-2,5 tetrazolium bromide (MTT) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA).
Cell culture
Primary cultures of human bone marrow fibroblasts (from healthy donors)
were from the National Centre for Cell Science, Pune, India. They were
maintained in 20% Iscove's modified Dulbecco's medium. For culturing
human peripheral blood lymphocytes, venous blood from healthy donors aged
23—31 years were collected using heparinized vacutainer tubes. Lymphocytes
were isolated using Ficoll-paque and cultured in Roswell Park Memorial
Institute (RPMI) 1640 medium containing 10% fetal calf serum, 2 mM L-
glutamine, 100 U/ml penicillin, 100 ug/ml streptomycin and 2% PHA.
All cell lines, except the CHO were cultured in Dulbecco's modified
medium plus 10% fetal calf serum and 2 mM L-glutamine and gentamycin
sulphate (50 ug/ml) at 37°C in an incubator containing 5% CO?. The CHO
cells were maintained in Eagle's modified minimum essential medium (Row
Laboratories, Irvine, UK) supplemented with 10% adult bovine serum, 2 mM
L-glutamine and gentamycin sulphate (50 ug/ml) (Sigma Chemical Co.).
Cytotoxicity assay
Cells were seeded on 96-well plates (Nunc, Kamstrup, Denmark), cultured
for 1 day and then treated with different concentrations of cleistanthin B for
72 h at 37°C in 5% CO2 in a humidified atmosphere. Control cells were
grown under identical conditions. At the end of incubation, medium was
removed and MTT (5 mg/ml) was added and the cells were further incubated
for 4 h. After the incubation, the MTT solution covering the cells was
removed, DMSO was added to the wells and cell viability was determined
by measuring the absorbance in a MR 700 microplate reader with a test
wavelengh of 570 run and a reference wavelengh of 630 nm (Mosmann,
1983). The experiment was repeated three or four times and the variations
were <TH.
Chromatid aberration analysis
Subconfluent cultures of CHO cells in 25 cm2 flasks were incubated with
cleistanthin B (1-6 ug/ml) at 37°C for 30 min. Solvent (ethanol 0.05%)
and negative controls (without treatment) were maintained separately. After
treatment the cells were washed twice with PBS and incubated with fresh
medium for 3 h for recovery. Colcemid (Sigma Chemical Co.) at a final
concentration of 0.2 uM was added and the cells were incubated further
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Fig. 1. Effects of cleistanthin B on chromatids. CHO cells were treated with
cleistanthin and the chromatids were stained with Giemsa as described in
Materials and Methods (see CA analysis) (A) control (untreated);
(B) 6 ng/ml of toxin treatment showing a break; (C) 6 Hg/ml of toxin
treatment showing chromatid exchange; (D) 6 |ig/ml of toxin treatment
showing chromatids with multiple gaps.
Table I. Cytotoxicity of cleistanthin B in normal and tumour cell lines
Cell line G I J O ( M ) '
Normal cell lines
Human phenpheral blood lymphocytes (HPBL) 4.7 X10"4
Human bone marrow fibroblast (HBMF) 3.9 X10"4
Mouse embryo fibroblast (MEF) 3.6X10"4
Human oral fibroblast (Tig-7) 2.3X1CT4
Chinese Hamster Ovary (CHO) 2.OXKT5
Cancer cell lines
T cell leukaemia (MOLT-4) 4.0X 10"5
Cervix carcinoma (HeLa) 2.5XKT5
Breast carcinoma (MCF-7) 2.4 X10"5
Colon (Colo320) 1.6X10"3
Larynx (HEp-2) 1.2 xl(T5
Melanoma (SK-MEL-28) 1.0X10"5
Oral (KB) 9.5XKT6
Neuroblastoma (SK-N-MC) 5.5X10"6
Fibrosareoma (HT 1080) 4 OxlfT6
Cervix carcinoma (SiHa) 1,6X 1(T*
"GI^ was determined using M i l as described in Materials and Methods.
for 3 h Mitotic cells were collected in a centrifuge tube by gentle shake off.
The cells were treated with hypotonic solution of 0.075 M KC1 at 37°C for
2-3 rrun. The cells were then fixed with methanol : acetic acid (3:1). Air-
dned chromosome preparations were stained with 3% Giemsa solution in
Sorenson phosphate buffer (pH 6.8) for 5-7 min. The slides were coded and
200 well-spread metaphases were screened for chromatid aberrations (Evans
et al, 1984).
Micronucleus assay
Human phenpheral blood lymphocytes were exposed to different concentra-
tions of cleistanthin B for 24 and 48 h. After 18 h of culture in the presence
of cyt-B (5 |ig/ml), cells were fixed as described above. Two to three drops
of fixed cell suspension were dispensed onto the surface of cold microslides.
For each donor, 1500 binucleate cells per concentration were scored blind for
MN frequency in each treatment (Preston et al. 1981; Ishidate et al, 1988).
Viability test
About 5X103 CHO cells were seeded in 6-well tissue culture plates and
treated with desired amounts of the toxin and incubated at 37°C for 24 h in
a humidified atmosphere containing 5% CO5. After incubation, the cells were
trypsinized and resuspended in 0.4% erythrosin B in PBS. The percentage of
viable cells was determined by counting stained (dead) and unstained (live)
cells. The experiment was repeated three times and the experimental variation
was 2-5%.
DNA precipitation assay
Exponentially growing CHO cells were radiolabelled for 20 h with 0 1 |iCi/
ml [3H]-thymidine, (17 Ci/mmole; Bhabha Atomic Research Centre, Bombay,
India). DNA precipitation assay (Olive et al, 1988) was carried out using
labelled cells that were treated with different doses of cleistanthin B for 24 h.
Briefly, cells were harvested with trypsin and about 3.5X 105 cells were lysed
for 1 min in 0.5 ml solution containing 2% sodium dodecyl sulphate (SDS),
10 mM EDTA.10 mM Tns and 0.05 M NaOH. Then 0 5 ml of 0.12 M KC1
was added gently and the tubes were kept in a 65°C water bath for 10 min.
The tubes were subsequently cooled in ice for 20 min and centrifuged for
10 mm at 1000 g. The supernatant was decanted into a scintillation vial and
1 ml of 0.05 M HC1 was added. The pellet was dissolved in 2X1 ml distilled
water at 65°C, vortexed and poured into a scintillation vial. Radioactivities
in the supernatant and the pellet fractions were measured in a liquid
scintillation counter.
Assessment of apoptosis
CHO cells (2X 106) were treated with indicated amounts of cleistanthin B for
24 h The cells were washed twice in PBS and centrifuged at 700 g. The cell
pellet was then treated with 100 (il of lysis buffer (1% NP-40, 50mM Tns,
20mM EDTA) After centrifugation for 5 min at 1600 g, the supernatant was
collected and the pellet was treated again with the same amount of lysis
buffer. The supematants were brought to 1 % SDS and incubated for 2 h with
5 Hg/ml of RNase A at 56°C followed by digestion with proteinase K
(2.5 |ig/ml) for at least 2h at 37°C. After addition of 1/2 vol 10 M ammonium
acetate the DNA was precipitated with 2.5 vol ethanol, dissolved in gel loading
buffer and separated by electrophoresis in 1.5% agarose gels. (Herrmann et al,
1994)
Statistical analysis
Student's /-test (Student-Newman Keul's test) was used to compare the
aberrations between the control and treated cells
Results
Cytotoxic effects of cleistanthin B
Cleistanthin B was tested for cytotoxicity against a broad
spectrum of normal and tumour cell lines. Cytotoxic effect
was monitored by determining the viability of cells based on
their ability to reduce MTT. The GI50 values for five normal
and 10 cancer cell lines were determined and the results are
shown in Table I. The GI50 values of cleistanthin B range
from 2X1O"5M to 4.7X10"4 M for the normal cells and
1.6X 10"6 to 4X 10"5M for the tumour cells.
Effect of cleistanthin B on the induction of chromatid
aberrations
Exposure of CHO cells for 30 min to cleistanthin B resulted
in characteristic induction of chromatid-type aberrations (Table
11 and Figure 1). Statistical analysis showed that there is a
significant difference in the extent of aberrations between the
control and the treated cells, at all the concentrations (P <
0.001). In the toxin treated cells a dose-dependent increase in
the yield of chromatid aberrations and isochromatid breaks
was observed. The exchange aberrations were not dose-
dependent. At 6 H-g/ml, and above the toxin induced extensive
gaps in chromatids (Figure 1). The chromatid aberrations occur
at doses that are well below those showing significant loss of
viability or double-strand breaks in DNA (Table II).
Effects of cleistanthin B on DNA strand breakage and cell
survival
CHO cells when treated with low doses of cleistanthin B for
a short time (30 min) caused CA, but neither significantly
affected the cell viability nor DNA strand breaks (Table II).
Therefore high doses of the toxin were used for viability and
strand-break assays. The percent survival values for CHO cells
treated with 20. 40. 60 and 80 ng/ml of the toxin for 24 h
were 72, 61, 53 and 43% respectively (Figure 2). The results
indicate a progressive decrease in the survival of cells in
response to increasing doses of cleistanthin B. DNA precipita-
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Fig. 2. DNA precipitation and viability assays. Cells were treated with 5-80 Hg/ral of cleistanthin and percentage of DNA precipitated and percentage
survival after 24 h were determined. The percentages were normalized to that of the control (untreated) cells. Results given are the means of triplicate
measurements. Error bars represent SEM.
Table II. Effects of cleistanthin B on the frequencies of chromatid-type aberrations, viability and DNA strand breaks in CHO cells
ClataUntliln B NormalCall!
Abnormal
Calls
Chrom* tid
AbarraUona
Aberrations per 100 cells
laochromaUd
braatto
Cnroxatld
exchanga
Total ab*rratk>na
(Gap)
% VlablHy * DNA atrand
braaka
188
109
108
IBS
ISO
148
lit
120
SO
47
1
44
32
32
40
32
82
7S
110
133
0 S
2
18
27
12
0
0
2
4
2
10
0 S
2
20 <
16 <
22 <
28 <
c
37
4 . =
0
0
0
0
0
0
10
10<
u
w
er
M
*200 cells were scored in each case after 30 min exposure to the toxin followed by 3 h incubation without toxin and a further 3 h with colcemid.
bControl 1 = negative control; control 2 = solvent control.
CP < 0.001% level (Student's Mest).
''N.S. = not scorable since the gaps were numerous.
'Viability of cells after 30 min exposure to the toxin and 6 h recovery in the absence of toxin was determined by the MTT assay.
fDNA strand breaks were monitored under the same conditions as for viability.
tion assay was done under identical conditions as that used
for the cell viability assay. Treatment of CHO cells with
cleistanthin B at concentrations of 20, 40, 60 and 80 \ig/m\
for 24 h showed 78%, 70, 65 and 62% precipitation of DNA
respectively in comparison with the control (Figure 2). The
dose-dependent decrease in the percentage of precipitated
DNA indicate DNA strand breaks.
Induction of apoptosis by cleistanthin B
The induction of strand breaks in DNA and loss of cell
viability caused by cleistanthin B may be explained by its
ability to induce apoptosis. Cleistanthin B indeed induced
programmed cell death in cells that were treated with 10-20
Hg/ml of toxin for 24 h. Agarose gel electrophoresis of DNA
from the treated cells showed nucleosome-like ladder pattern
(Figure 3). The DNA fragments in the ladder ranged from
185 bp and its multiples up to 2500 bp.
Induction of micronuclei formation by cleistanthin
The frequency of occurrence of MN in cultured human blood
lymphocytes following cleistanthin B treatment is shown in
Table III and Figure 4. Human blood lymphocytes treated with
2-10 Hg/ml of cleistanthin B for 24 and 48 h showed formation
of micronuclei. At 24 h of treatment there was a definite
increase in MN formation when the cells were exposed to 2 -
10 |ig/ml of cleistanthin B (Table HI). The dose-dependant
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Table III. Effects of cleistanthin B on nucronucleus formation in lymphocytes
S.No
Treatment Total No. of Total No. of No. of MN/BN
pg/ml blnuclel (BN) a micronuclel (MN) 1 2 3 4
Average MN/1000
BN ± SD
24 h
1
2
3
4
5
6
7
8
9
to
t1
12
13
14
Control I
c
Control II
2
4
6
8
10
48 h
Control I c
Control I I c
2
A
6
8
10
3000
3000
3000
3000
3000
3000
3000
3000
3000
3000
3000
3000
3000
2000
12
15
m
43
60
70
74
14
16
51
84
73
81
65
12 0 0 0
15 0 0 0
39 4 1 0
37 3 0 0
44 2 4 0
54 5 2 0
49 8 3 0
14 0 0 0
16 0 0 0
41 5 0 0
55 8 3 1
53 7 2 0
67 4 2 0
40 6 3 1
4 ± 0.82
5 ± 0.82
16.7 ± 2.30 d
14.3 ± 2.49 d
20.0 ± 2.60 d
23.3 ± 4.1 d
24.6 ± 3.8 d
4.7 ± 0.47
5.3 ± 0.94
17.0 ± 2.16 d
28.0 ± 0.82 d
24.3 ± 2.49 d
27.0 ± 1.4 d
32.5 ± 1.2 d
'1500 BN were scored from each donor
bCleistanthin B at 10 |ig/ml caused appreciable loss of cells due to high toxicity. therefore. 1000 BM were used.
cControl I = negative control; control 2 = solvent control
dP < 0.01 (Student's Mest)
1 2 3
564 —
26 9 -
Fig. 3. Agarose gel electrophoresis of DNA from CHO cells treated with
cleistanthin B. Cells were exposed to various amounts of toxin. DNA was
isolated and analysed as described in Materials and Methods. Lane 1 DNA
from untreated cells; lanes 2-4 respectively contained DNA from cells
treated with 10 and 20 |ig/ml of toxin.
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increase was more pronounced at 48 h of treatment in which
4—6 (lg/ml of toxin led to an increase of 54% in MN formation
over that observed with 2
Discussion
Many anti-tumour compounds are derived from plants. Crude
extracts of C.collinus plant were reported to possess anti-
tumour effects in epidermal carcinoma cells in culture (Bhakuni
et ai, 1969). In this study, we have purified one of the toxic
principles namely cleistanthin B from C.collinus and assessed
its anti-proliferative activity using cultured cell lines. Cleistan-
thin B was found to be toxic to normal and tumour cell lines.
Even in the tumour cell lines, some were less sensitive to
cleistanthin B than others. The tumour cell line that showed
the least sensitivity is the T cell leukaemia (Molt-4) while the
cervical carcinoma (SiHa) cells are highly sensitive to this
compound. Other tumour cells (Table I) show sensitivity
in between the above. Cleistanthin B appears to have low
cytotoxicity against normal human cells like bone marrow
fibroblasts, peripheral blood lymphocytes and oral fibroblasts
(Table I)- CHO cells were as sensitive as human T-cell
leukaemia, cervical carcinoma and breast cancer cells. How-
ever, it may not be appropriate to compare a hamster cell line
with human cell lines. Although human cancer cell lines
showed higher sensitivity to this toxin than the three human
 by guest on June 22, 2011
m
utage.oxfordjournals.org
D
ow
nloaded from
 
Cytotoxic and genotoxic effects of delstanthln B
B
Fig. 4. Induction of micronucleus formation by cleistanthin B. Cultured lymphocytes were treated with 2-10 Hg/ml of toxin and the micronuclei were
monitored as described in Materials and Methods. (A) untreated control; (B-D) 4 Jig/ml of toxin treatment for 48 h.
normal cell types examined (Table I), the best way of compar-
ison would be with the corresponding normal cells such as
comparison of carcinomas with normal epithelial cells.
Treatment of cultured cells with cleistanthin B resulted in
the production of many chromatid aberrations. However, there
was a significant difference in the survival doses and the dose
which induced aberrations. The aberrations were induced at
low concentrations of the chemical, well below that which
induced significant cell death. At low doses the damage
induced by this compound may be repairable and therefore
the survival of the cells were not affected. This is also
supported by the low induction of MN in cells treated with
low concentrations of the toxin for longer time.
The adverse effects of cleistanthin B on DNA and chromo-
somes and subsequent loss of viability suggest that the cell
death caused by the toxin is probably by apoptosis. A number of
anti-tumour agents including enediyene, cisplatin, bleomycin,
camptothecin doxorubicin and etoposide have been shown to
induce cell death by apoptosis (Wrasidlo et al., 1994; Waldman
et al., 1996). The nucleosome-like DNA ladders observed
upon electrophoresis of DNA from the toxin-treated cells
suggest that cleistanthin also induces cell death by apoptosis.
The higher sensitivity of tumour cells to cleistanthin and the
apoptotic death caused by this toxin indicate that cleistanthin
is a potential candidate for cancer chemotherapy, provided its
selectivity against tumour cells versus normal cells can be
maintained and enhanced in animal models and humans.
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